Materion Corporation · NYSE:MTRN
Materion — Merger or Acquisition (June 2020)
9 slides from Materion's merger presentation, Jun 8, 2020
Slide 1: Optics Balzers Acquisition Creates a Global Leader in Optical Thin Film Coatings
Exhibit 99.2 Optics Balzers Acquisition Creates a Global Leader in Optical Thin Film Coatings June 8, 2020
Slide 2: Forward-Looking Statements Disclaimer
Forward-Looking Statements Disclaimer These slides contain (and the accompanying oral discussion will contain, where applicable) “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties an
Slide 3: Strategic Acquisition of Optics Balzers Accelerates Growth in Precision Coatings
Strategic Acquisition of Optics Balzers Accelerates Growth in Precision Coatings Industry-leading optical thin film coating solutions provider with ✓ advanced technologies and globally recognized brand Highly complementary fit across ✓ geographies, technologies and end markets Strong financial metri
Slide 4: Transaction Overview
Transaction Overview ▪ $160 million enterprise value Transaction ▪ Represents 12x LTM EBITDA, 8x including synergies Value ▪ Expected to be accretive to EBITDA margin, growth and earnings ▪ Accelerate revenue growth with increased customer, geographic and end market exposure Synergies ▪ Leverage pro
Slide 5: Optics Balzers is a Global Leader in Optical Thin Film Coating Solutions
Optics Balzers is a Global Leader in Optical Thin Film Coating Solutions Company Overview Summary Financials (TTM 3/31/20) Total Revenue Adj. EBITDA Adj. EBITDA Margin ► Leading optical thin film coating solutions provider $67 $13 20% ► Broad, highly differentiated million million product portfolio
Slide 6: Expands Portfolio to Serve Attractive Markets with Exposure to Key Megatrends
Expands Portfolio to Serve Attractive Markets with Exposure to Key Megatrends End Market Illustrative Applications Key Megatrends ► Fluorescence microscopy ► Opthalmologic surgery ► DNA Microarrays (Biochips) Digital Medicine Life Sciences 33% of Revenue Gene Therapy ► Wafer level optics Health + We
Slide 7: Combination Creates an Industry Leading Portfolio in Precision Coatings
Combination Creates an Industry Leading Portfolio in Precision Coatings Globally Balanced Revenue Improved End Market Diversification FY 2019 Pro Forma Optics FY 2019 Pro Forma Optics Other Automotive 6% Asia 4% Life Sciences 27% 26% N.A. Consumer 38% 17% EMEA Aerospace & Industrial 35% Defense 25%
Slide 8: Highly Complementary Platforms Drive Multiple Synergy Opportunities
Highly Complementary Platforms Drive Multiple Synergy Opportunities Leverage Optics Balzers’ Leverage Materion’s portfolio to drive growth portfolio to drive growth in the U.S. in Europe and Asia Accelerate Profitable Global Growth Advance innovation and Expand Materion expand served markets operati
Slide 9: Acquisition of Optics Balzers is Consistent with Materion's Strategic Objectives
Acquisition of Optics Balzers is Consistent with Materion’s Strategic Objectives Expand portfolio of highly differentiated advanced materials solutions Geographic revenue and manufacturing expansion Increase penetration in high-growth markets Advance technical capabilities and innovation acros